Mild To Moderate Major Depressive Disorder clinical trials

Explore recruiting mild to moderate major depressive disorder clinical trials.

Recruiting mild to moderate major depressive disorder studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Mild To Moderate Major Depressive Disorder trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Multi-centre, double-blind, placebo-controlled, randomised trial to prove the efficacy and safety of Silexan® (WS®1265) in patients with a major depressive episode of mild to moderate severity

Germany, Austria

Therapeutic confirmatory (Phase III) EU CTIS Study details

Mild To Moderate Major Depressive Disorder trials by city

Mild To Moderate Major Depressive Disorder in Toronto Mild To Moderate Major Depressive Disorder in Vancouver Mild To Moderate Major Depressive Disorder in Montreal Mild To Moderate Major Depressive Disorder in Calgary Mild To Moderate Major Depressive Disorder in Edmonton Mild To Moderate Major Depressive Disorder in Ottawa Mild To Moderate Major Depressive Disorder in Winnipeg Mild To Moderate Major Depressive Disorder in Quebec City Mild To Moderate Major Depressive Disorder in Hamilton Mild To Moderate Major Depressive Disorder in Kitchener Mild To Moderate Major Depressive Disorder in London Mild To Moderate Major Depressive Disorder in Halifax Mild To Moderate Major Depressive Disorder in New York Mild To Moderate Major Depressive Disorder in Los Angeles Mild To Moderate Major Depressive Disorder in Chicago Mild To Moderate Major Depressive Disorder in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease